ICCM - IceCure Medical Ltd.'s (ICCM) CEO Eyal Shamir on Q1 2022 Results - Earnings Call Transcript

IceCure Medical Ltd. (ICCM) Q1 2022 Earnings Conference Call May 18, 2022 8:30 AM ET Company Participants Eyal Shamir - Chief Executive Officer Ronen Tsimerman - Chief Financial Officer and Chief Operating Officer Richard Fine - Investigator of ICE3 Clinical Trial Conference Call Participants Ben Haynor - Alliance Global Partners Kemp Dolliver - Brookline Capital Markets Presentation Operator Welcome to IceCure’s First Quarter 2022 Results Conference Call. Management will provide an overview of IceCure’s financial results as well as clinical and operational highlights. On the call today are IceCure’s CEO, Eyal Shamir and CFO, Ronen Tsimerman. They are joined today by Dr. Richard Fine. Dr. Fine is a trial investigator for IceCure’s ICE3 clinical trial on cryoablation of small Low-Risk Breast cancer. Dr. Fine is also a past President and Chairman of the American Society of American Society of Breast Surgeons, Program Director of the Breast Surgical Oncology Fellowship and

For further details see:

IceCure Medical Ltd.'s (ICCM) CEO Eyal Shamir on Q1 2022 Results - Earnings Call Transcript